[1]
Pichai, E., J., E.R. and Sandanapitchai, V. 2016. Efficacy and safety of ivabradine as an add-on to atenolol in patients with chronic stable ischemic heart disease. International Journal of Basic & Clinical Pharmacology. 5, 6 (Dec. 2016), 2546–2551. DOI:https://doi.org/10.18203/2319-2003.ijbcp20164121.